[
  {
    "ts": "2025-10-28T16:10:02+00:00",
    "headline": "Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?",
    "summary": "Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "url": "https://finance.yahoo.com/news/solventum-solv-beat-estimates-again-161002191.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8b681f26-5954-31bb-9784-1567f3ee9000",
      "content": {
        "id": "8b681f26-5954-31bb-9784-1567f3ee9000",
        "contentType": "STORY",
        "title": "Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?",
        "description": "",
        "summary": "Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
        "pubDate": "2025-10-28T16:10:02Z",
        "displayTime": "2025-10-28T16:10:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CWazdtIY_OpVNPwmJabcjQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S8TA.VI0J48dh2TXqKSlJQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/solventum-solv-beat-estimates-again-161002191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/solventum-solv-beat-estimates-again-161002191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SOLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-28T13:00:03+00:00",
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-130003772.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "4f4d84a6-4fe2-3bef-a134-52ed8ac657c0",
      "content": {
        "id": "4f4d84a6-4fe2-3bef-a134-52ed8ac657c0",
        "contentType": "STORY",
        "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
        "description": "",
        "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
        "pubDate": "2025-10-28T13:00:03Z",
        "displayTime": "2025-10-28T13:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee",
          "originalWidth": 900,
          "originalHeight": 876,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/H7_MbG.UY.XzK7FHlqhSdQ--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee.cf.webp",
              "width": 900,
              "height": 876,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9cdhr7KlQi2r1salrGcJQg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-130003772.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-130003772.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            },
            {
              "symbol": "SOLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-28T04:04:31+00:00",
    "headline": "3 Reasons to Avoid SOLV and 1 Stock to Buy Instead",
    "summary": "While the S&P 500 is up 24.4% since April 2025, Solventum (currently trading at $71.44 per share) has lagged behind, posting a return of 8.1%. This may have investors wondering how to approach the situation.",
    "url": "https://finance.yahoo.com/news/3-reasons-avoid-solv-1-040431511.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "80dd907a-533e-304c-ac27-9de86b088817",
      "content": {
        "id": "80dd907a-533e-304c-ac27-9de86b088817",
        "contentType": "STORY",
        "title": "3 Reasons to Avoid SOLV and 1 Stock to Buy Instead",
        "description": "",
        "summary": "While the S&P 500 is up 24.4% since April 2025, Solventum (currently trading at $71.44 per share) has lagged behind, posting a return of 8.1%. This may have investors wondering how to approach the situation.",
        "pubDate": "2025-10-28T04:04:31Z",
        "displayTime": "2025-10-28T04:04:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/4713de89bf2a4b23c419e5d895724d29",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "SOLV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9sodVPOfrt0hXGFQBy6JWQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/4713de89bf2a4b23c419e5d895724d29.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GWFYYzt49miTZTcaQ9qDsw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/4713de89bf2a4b23c419e5d895724d29.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-avoid-solv-1-040431511.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-avoid-solv-1-040431511.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SOLV"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]